Tenaya Therapeutics (TNYA) Payables (2020 - 2026)

Tenaya Therapeutics has reported Payables for 7 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 62.2% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 62.2% YoY), and the FY2025 full-year result was $3.6 million, down 30.63% from the prior year.
• Payables for Q1 2026 stood at $1.9 million, down from $3.6 million in the prior quarter.
• The five-year high for Payables was $9.6 million in Q4 2022, with the low at $1.9 million in Q1 2026.
• Average Payables over 5 years is $5.6 million, with a median of $5.3 million recorded in 2022.
• Year-over-year, Payables jumped 58.67% in 2023 and sank 62.2% in 2026.
• Tracing TNYA's Payables over 5 years: stood at $9.6 million in 2022, then tumbled by 41.22% to $5.6 million in 2023, then decreased by 8.31% to $5.2 million in 2024, then tumbled by 30.63% to $3.6 million in 2025, then tumbled by 46.55% to $1.9 million in 2026.
• The last three Payables figures came in at $1.9 million (Q1 2026), $3.6 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison